Northwest Eye Clinical Research Update: The Glaukos iDose GC-012 Study
iDose GC-012 Study,Provider Newsletter,Uncategorized
Study Overview Northwest Eye Surgeons is happy to announce that Drs. Cameron and Kuzin are Principal Investigators in an active FDA approved Phase III clinical study on iDose Travoprost Intraocular Implants. This is a prospective, randomized masked three year study comparing novel implantable glaucoma medication delivery devices to topical timolol. One of two biocompatible…
Read More
